Stock-Based Compensation (Summarized Stock Option Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024	Jun. 30, 2024	Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding, Number of shares, Beginning Balance			4,918,248	673,274	673,274
Exercised	(19,331)	(15,832)	(36,345)	(23,217)
Forfeitures, Number of shares			(13,333)	(195,739)
Outstanding, Number of shares, Ending Balance	5,868,570	954,318	5,868,570	954,318	4,918,248	673,274
Exercisable, Number of Shares	387,901		387,901
Vested and expected to vest, Number of shares	5,868,570		5,868,570
Outstanding, Weighted average exercise price, Beginning Balance			$ 8.70	$ 4.37	$ 4.37
Exercised, Weighted average exercise price			3.02	1.20
Forfeitures, Weighted average exercise price			11.23	3.93
Outstanding, Weighted average exercise price, Ending Balance	$ 8.71	$ 4.03	8.71	$ 4.03	$ 8.70	$ 4.37
Exercisable, Weighted average exercise price	4.58		4.58
Vested and expected to vest, Weighted average exercise price	$ 8.71		$ 8.71
Outstanding, Weighted average remaining contractual term (in years)			3 years 9 months 14 days	5 years 2 months 26 days	4 years 6 months 3 days	5 years 1 month 20 days
Exercisable, Weighted average remaining contractual term (in years)			4 years 10 months 28 days
Vested and expected to vest, Weighted average remaining contractual term (in years)			3 years 9 months 14 days
Outstanding, Aggregate intrinsic value, Beginning Balance			$ 889	$ 239	$ 239
Vested and expecting to vest, Aggregate intrinsic value	$ 886		886
Exercised, Aggregate intrinsic value			70	14
Exercisable, Aggregate intrinsic value	285		285
Outstanding, Aggregate intrinsic value, Ending Balance	$ 886	$ 45	$ 886	$ 45	$ 889	$ 239
Outstanding, Weighted average grant date fair value, Beginning Balance			$ 1.77	$ 1.67	$ 1.67
Forfeitures, Weighted average grant date fair value			8.83	1.39
Outstanding, Weighted average grant date fair value, Ending Balance	$ 1.20	$ 1.78	$ 1.20	$ 1.78	$ 1.77	$ 1.67
December 2023 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of shares				500,000
Granted, Weighted average exercise price				$ 3.50
Granted, Weighted average remaining contractual term (in years)				5 years 2 months 1 day
Granted, Aggregate intrinsic value				$ 880
Granted, Weighted average grant date fair value				$ 1.76
December 2024 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of shares			350,000
Granted, Weighted average exercise price			$ 6.00
Granted, Weighted average remaining contractual term (in years)			2 years
Granted, Aggregate intrinsic value			$ 433
Granted, Weighted average grant date fair value			$ 1.24
December 2024 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of shares			250,000
Granted, Weighted average exercise price			$ 8.00
Granted, Weighted average remaining contractual term (in years)			2 years
Granted, Aggregate intrinsic value			$ 177
Granted, Weighted average grant date fair value			$ 0.71
January 2025 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of shares			100,000
Granted, Weighted average exercise price			$ 8.00
Granted, Weighted average remaining contractual term (in years)			2 years
Granted, Aggregate intrinsic value			$ 71
Granted, Weighted average grant date fair value			$ 0.71
January 2025 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of shares			150,000
Granted, Weighted average exercise price			$ 11.00
Granted, Weighted average remaining contractual term (in years)			2 years
Granted, Aggregate intrinsic value			$ 107
Granted, Weighted average grant date fair value			$ 0.71
January 2025 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of shares			150,000
Granted, Weighted average exercise price			$ 14.00
Granted, Weighted average remaining contractual term (in years)			2 years
Granted, Aggregate intrinsic value			$ 123
Granted, Weighted average grant date fair value			$ 0.82